WESTBROOK, Maine, Oct. 14, 2014 /PRNewswire/ -- IDEXX
Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its
2014 third quarter financial results for Friday, October 24, 2014 at approximately
7:00 a.m. ET. The Company will
conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Individuals can access a live webcast of the conference call
through a link on the IDEXX website, http://www.idexx.com. An
archived edition of the webcast will be available after
1:00 p.m. ET on that day via the same
link and will remain available for one year.
The live call also will be accessible by telephone. To listen to
the live conference call, please dial 800-230-1074 or 612-234-9960
and reference confirmation code 338991. Replay of the conference
call will be available through Friday,
October 31, 2014 by dialing 320-365-3844 and referencing
replay code 338991.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a
leader in pet healthcare innovation, serving practicing
veterinarians around the world with a broad range of diagnostic and
information technology-based products and services. IDEXX products
enhance the ability of veterinarians to provide advanced medical
care, improve staff efficiency and build more economically
successful practices. IDEXX is also a worldwide leader in providing
diagnostic tests and information for livestock and poultry and
tests for the quality and safety of water and milk. Headquartered
in Maine, IDEXX Laboratories
employs more than 5,900 people and offers products to customers in
over 175 countries.
Note Regarding Forward-Looking Statements
This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are based on management's current
expectations and beliefs, as well as a number of assumptions
concerning future events. These statements are subject to risks,
uncertainties, assumptions and other important factors. Readers are
cautioned not to put undue reliance on such forward-looking
statements because actual results may vary materially from those
expressed or implied. The reports filed by the Company pursuant to
United States securities laws
contain discussions of these risks and uncertainties. The Company
assumes no obligation to, and expressly disclaims any obligation
to, update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise. Readers are
advised to review the Company's filings with the United States
Securities and Exchange Commission (which are available from the
SEC's EDGAR database at www.sec.gov, at various SEC reference
facilities in the United States
and via the Company's website at www.idexx.com).
Contact: Bonnie Reid, Investor
Relations, 1-207-556-8155
Logo -
http://photos.prnewswire.com/prnh/20110602/NE13041LOGO
SOURCE IDEXX Laboratories, Inc.